EUVIMEDUpptäck EUVIMED
Open access · CC BY-NC 4.0

Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro

Lara Kristina Klauer, Olga Schutti, Selda Ugur, Fatemeh Doraneh-Gard, Daniel Christoph Amberger, Nicole Rogers, Doris Krämer, Andreas Rank, Christoph Schmid, Britta Eiz-Vesper, Helga Maria Schmetzer

Transfusion Medicine and Hemotherapy · 2022 · 49 (1) · 44-61

DOI: 10.1159/000516886 ↗

At a glance

Journal article in Transfusion Medicine and Hemotherapy, published online on 2021-07-07. Written by Lara Kristina Klauer and 10 co-authors. Institution: Department of Medicine III, University Hospital of Munich, Munich, Germany. Cited 22 times so far (Crossref); 61 references. The full text is freely available (open access, CC BY-NC 4.0).

AbstractSubjectsBibliografiska uppgifterCiteRelated studies

Abstract (original language)

Introduction

Myeloid leukaemic blasts can be converted into leukaemia-derived dendritic cells (DCleu), characterised by the simultaneous expression of dendritic- and leukaemia-associated antigens, which have the competence to prime and enhance (leukaemia-specific) immune responses with the whole leukaemic antigen repertoire. To display and further specify dendritic cell (DC)- and DCleu-mediated immune responses, we analysed the interferon gamma (IFNy) secretion of innate and adaptive immune cells.

Methods

DC/DCleu were generated from leukaemic whole blood (WB) with (blast)modulatory Kit-I (granulocyte-macrophage colony-stimulating factor [GM-CSF] + Picibanil [OK-432]) and Kit-M (GM-CSF + prostaglandin E1) and were used to stimulate T cell-enriched immunoreactive cells. Initiated anti-leukaemic cytotoxicity was investigated with a cytotoxicity fluorolysis assay. Initiated IFNy secretion of T, NK, CIK, and iNKT cells was investigated with a cytokine secretion assay (CSA). IFNy positivity was additionally evaluated with an intracellular cytokine assay (ICA). Recent activation of leukaemia-specific cells was verified through addition of leukaemia-associated antigens (LAA; WT-1 and Prame)

Results

We found Kit-I and Kit-M competent to generate mature DC and DCleu from leukaemic WB without induction of blast proliferation. Stimulation of immunoreactive cells with DC/DCleu regularly resulted in an increased anti-leukaemic cytotoxicity and increased IFNy secretion of T, NK, and CIK cells, pointing to the significant role of DC/DCleu in leukaemia-specific alongside anti-leukaemic reactions. Interestingly, an addition of LAA did not further increase IFNy secretion, suggesting an efficient activation of leukaemia-specific cells. Here, both the CSA and ICA yielded comparable frequencies of IFNy-positive cells. Remarkably, the anti-leukaemic cytotoxicity positively correlated with the IFNy secretion in TCD3+, TCD4+, TCD8+, and NKCD56+ cells.

Conclusion

Ultimately, the IFNy secretion of innate and adaptive immune cells appeared to be a suitable parameter to assess and monitor the efficacy of in vitro and potentially in vivo acute myeloid leukaemia immunotherapy. The CSA in this regard proved to be a convenient and reproducible technique to detect and phenotypically characterise IFNy-secreting cells. In respect to our studies on DC-based immunomodulation, we were able to display the potential of DC/DCleu to induce or improve leukaemia-specific and anti-leukaemic activity.

Subjects

Author keywords

Acute myeloid leukaemiaAnti-leukaemic functionalityCytokine secretion assayLeukaemia-derived dendritic cellsLeukaemia-specific cells

Authors and institutions

  • Department of Medicine III, University Hospital of Munich, Munich, Germany.
  • Department of Haematology and Oncology, St.-Josefs-Hospital, Hagen, Germany.
  • Department of Haematology and Oncology, University Hospital of Augsburg, Augsburg, Germany.
  • Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany.

Cite

APA

Klauer, L. K., Schutti, O., Ugur, S., Doraneh-Gard, F., Amberger, D. C., Rogers, N., Krämer, D., Rank, A., Schmid, C., Eiz-Vesper, B., & Schmetzer, H. M. (2022). Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro. Transfusion Medicine and Hemotherapy, 49(1), 44-61. https://doi.org/10.1159/000516886

Vancouver

Klauer LK, Schutti O, Ugur S, Doraneh-Gard F, Amberger DC, Rogers N, et al. Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro. Transfusion Medicine and Hemotherapy. 2022;49(1):44-61. doi:10.1159/000516886

BibTeX
@article{Klauer2022,
  author = {Klauer, Lara Kristina and Schutti, Olga and Ugur, Selda and Doraneh-Gard, Fatemeh and Amberger, Daniel Christoph and Rogers, Nicole and Krämer, Doris and Rank, Andreas and Schmid, Christoph and Eiz-Vesper, Britta and Schmetzer, Helga Maria},
  title = {Interferon Gamma Secretion of Adaptive and Innate Immune Cells as a Parameter to Describe Leukaemia-Derived Dendritic-Cell-Mediated Immune Responses in Acute Myeloid Leukaemia in vitro},
  journal = {Transfusion Medicine and Hemotherapy},
  year = {2022},
  volume = {49},
  number = {1},
  pages = {44--61},
  doi = {10.1159/000516886}
}
Start for free →